Professional Overview
Dimitrios Skaltsas is the Co-founder and CEO of Intelligencia AI, a leading health technology company specializing in artificial intelligence-driven solutions aimed at reducing the risks and accelerating decision-making in pharmaceutical drug development. Operating from New York, with additional offices in San Francisco and Athens, Intelligencia AI employs approximately 110 employees globally.
Educational Background
Dimitrios holds an MBA from INSEAD (Class of 2011), a law degree from University College London (UCL), and a law degree from the University of Athens. His diverse academic background combines legal training with advanced business education, underpinning his leadership in a technologically complex and highly regulated industry.
Career Trajectory
Prior to founding Intelligencia AI, Dimitrios led the Big Data and AI department at McKinsey New Ventures, bringing substantial expertise in data-driven decision-making and innovation strategy. He began his professional career as an attorney before transitioning full-time to health technology and AI entrepreneurship.
Leadership and Strategic Focus
As CEO and co-founder since Intelligencia AI's inception in 2017, Dimitrios drives the company’s business and investment growth strategy with a strong emphasis on innovation at the intersection of AI, biomedical expertise, and life sciences. He focuses on delivering explainable, transparent, and unbiased AI-powered SaaS solutions that provide actionable insights into the probability of success for clinical trials.
Dimitrios emphasizes building products tightly aligned with customer needs in pharmaceutical R&D, aiming to improve research productivity, reduce the risk of clinical research, and accelerate the path to market for life-changing therapies.
Company Performance and Recognition Under His Leadership
Under Dimitrios’s leadership, Intelligencia AI has demonstrated significant growth and industry impact:
- Ranked No. 90 on Inc. Magazine's 2024 Inc. 5000 Regionals: Northeast list of Fastest-Growing Private Companies, with an impressive two-year revenue growth of 184% (2020-2022).
- Successfully raised over $15 million in funding, including a $12 million investment led by MTIP announced in 2021, to expand AI-driven drug development solutions.
- Awarded a U.S. patent for its AI platform that provides accurate and transparent probability of drug success assessments, highlighting industry recognition of its technological edge.
- Demonstrated strong AI platform performance with an investment portfolio of top-ranked biotech assets yielding a 60% return and a Sharpe Ratio of 1.83, significantly outperforming industry benchmarks.
- Positioned as a top healthcare AI technology company focused on de-risking and optimizing the drug development process.
Thought Leadership and Industry Engagement
Dimitrios participates actively in the healthcare and AI community through interviews, podcasts, and panel discussions at major industry events such as the Basel Healthtech Conference. He frequently articulates the transformative potential of AI in pharma, advocating for scalable, data-driven solutions that enable better clinical development and commercial decision-making.
His leadership style integrates a passion for innovation with a commitment to positive societal impact, specifically by improving patient outcomes through advanced AI applications in drug development.
Summary of Key Attributes:
- Role: CEO and Co-founder, Intelligencia AI
- Location: New York, NY (with offices in San Francisco and Athens)
- Education: MBA (INSEAD), Law Degrees (UCL and University of Athens)
- Industry: Health Technology, Artificial Intelligence, Pharmaceutical Drug Development
- Achievements:
- Led company to 184% revenue growth, Inc. 5000 ranked
- Secured $15+ million funding
- Awarded U.S. patent for AI-powered drug success estimation
- Spearheaded product focusing on clear, unbiased clinical trial risk assessments
- Prior Experience: Head of Big Data and AI at McKinsey New Ventures, Attorney
- Professional Interests: AI innovation, data transparency, clinical development optimization, interdisciplinary technology solutions
Dimitrios Skaltsas exemplifies a blend of strategic business leadership, technical acumen, and deep domain expertise foundational to driving Intelligencia AI's market presence and technological advancements in healthcare AI.
